Related Experiment Video
Updated: Mar 6, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Closure of Dedicated TAVR Device for Aortic Regurgitation in LVAD Patients: An Expected Consequence?
Sara Bombace1, Karl-Philip Rommel1, Mehmet Oezkur2
1Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Abstract:
Severe aortic regurgitation (AR) in patients with left ventricular assist device (LVAD) causes recirculatory flow and hemodynamic compromise. Two LVAD patients with severe AR underwent transfemoral JenaValve Trilogy implantation. Both procedures achieved immediate abolition of regurgitation; however, both prostheses subsequently showed valve closure, with one case progressing to complete thrombotic sealing. Despite closed prosthetic valves, both patients demonstrated improved LVAD efficiency and absence of clinical embolic events at last available follow-up. JenaValve Trilogy implantation can provide hemodynamic benefit in high-risk LVAD patients, even when functional or thrombotic valve closure occurs. However, long-term durability and anticoagulation strategies remain to be determined.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
Cardiac Catheterization III: Left Heart Catheterization
Mitral Regurgitation III: Medical Management

